Vault-13

683 Capital Management, LLC

NEW YORK, NY · CIK 1404574 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2012 · limited liability company

As an employer

$1.4bn reported value -18.1% vs Q1 2022
268positions
30.5%in top 10
17 new 44 added 25 reduced 97 sold out vs Q1 2022

Options: 2 call positions ($12.9m notional), 1 put positions ($19.0m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ENOVA INTL INC COM ENVA ENVA 3,000,000 $86.5m6.25% 6.25% ReducedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m -49.0k -49,000 -1.6%
2 IAC INC COM NEW PPLI PPLI 613,200 $46.6m3.37% 3.37% AddedShares held: Q3 2021 306.9k, Q4 2021 759.8k, Q1 2022 596.7k, Q2 2022 613.2k +16.5k +16,500 2.8%
3 OPENDOOR TECHNOLOGIES INC COM OPEN OPEN 9,430,000 $44.4m3.21% 3.21% AddedShares held: Q3 2021 2.0m, Q4 2021 7.3m, Q1 2022 8.4m, Q2 2022 9.4m +1.0m +1,030,000 12.3%
4 CARVANA CO CL A CVNA CVNA 1,800,000 $40.6m2.94% 2.94% AddedShares held: Q3 2021 545.0k, Q4 2021 600.0k, Q1 2022 915.0k, Q2 2022 1.8m +885.0k +885,000 96.7%
5 GENERAL MTRS CO COM GM GM 1,205,400 $38.3m2.77% 2.77% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.2m
6 CARDLYTICS INC COM COM 1,684,741 $37.6m2.72% 2.72% AddedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.6m, Q2 2022 1.7m +115.7k +115,741 7.4%
7 LENNAR CORP CL A LEN LEN 493,900 $34.9m2.52% 2.52% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 253.1k, Q2 2022 493.9k +240.8k +240,800 95.1%
8 OCCIDENTAL PETE CORP *W EXP 08/03/202 OXY.WS OXY.WS 851,300 $31.5m2.27% 2.27% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 851.3k
9 HESS CORP COM HES HES 292,600 $31.0m2.24% 2.24% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 412.5k, Q2 2022 292.6k -119.9k -119,900 -29.1%
10 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,581,653 $30.4m2.20% 2.20% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.4m, Q1 2022 1.6m, Q2 2022 1.6m
11 TAILWIND ACQUISITION CORP COM CL A COM CL A 3,000,000 $29.9m2.16% 2.16% UnchangedShares held: Q3 2021 3.0m, Q4 2021 3.0m, Q1 2022 3.0m, Q2 2022 3.0m
12 UNIQURE NV SHS QURE QURE 1,355,000 $25.3m1.82% 1.82% UnchangedShares held: Q3 2021 711.4k, Q4 2021 1.3m, Q1 2022 1.4m, Q2 2022 1.4m
13 CONCORD ACQUISITION CORP III COM CL A COM CL A 2,475,000 $24.6m1.78% 1.78% UnchangedShares held: Q3 2021 0, Q4 2021 475.0k, Q1 2022 2.5m, Q2 2022 2.5m
14 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 7,521,248 $24.4m1.77% 1.77% AddedShares held: Q3 2021 563.0k, Q4 2021 187.1k, Q1 2022 462.0k, Q2 2022 7.5m +7.1m +7,059,201 1527.8%
15 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 3,865,000 $24.4m1.76% 1.76% AddedShares held: Q3 2021 3.2m, Q4 2021 3.3m, Q1 2022 3.4m, Q2 2022 3.9m +490.0k +490,000 14.5%
16 CONCORD ACQUISITION CORP II COM CL A CNDA CNDA 2,475,000 $23.9m1.73% 1.73% UnchangedShares held: Q3 2021 0, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
17 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 2,000,000 $22.1m1.60% 1.60% AddedShares held: Q3 2021 949.8k, Q4 2021 720.0k, Q1 2022 1.5m, Q2 2022 2.0m +500.0k +500,000 33.3%
18 ERO COPPER CORP COM ERO ERO 2,560,000 $21.6m1.56% 1.56% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.5m, Q2 2022 2.6m +1.0m +1,035,000 67.9%
19 AFFIMED N V COM COM 7,665,000 $21.2m1.53% 1.53% AddedShares held: Q3 2021 5.6m, Q4 2021 5.9m, Q1 2022 6.1m, Q2 2022 7.7m +1.5m +1,525,000 24.8%
20 TIO TECH A CLASS A ORD SHS CLASS A ORD SHS 2,000,000 $19.5m1.41% 1.41% UnchangedShares held: Q3 2021 2.0m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
21 CRIXUS BH3 ACQUISITION CO CLASS A COM CLASS A COM 1,980,000 $19.5m1.41% 1.41% UnchangedShares held: Q3 2021 0, Q4 2021 1.9m, Q1 2022 2.0m, Q2 2022 2.0m
22 LOGISTICS INNOVTN TECHNLGS C CLASS A COM CLASS A COM 1,999,999 $19.4m1.40% 1.40% UnchangedShares held: Q3 2021 1.9m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
23 HAWKS ACQUISITION CORP CL A CL A 1,980,000 $19.3m1.40% 1.40% UnchangedShares held: Q3 2021 0, Q4 2021 1.3m, Q1 2022 2.0m, Q2 2022 2.0m
24 INSPIRED ENTMT INC COM INSE INSE 2,200,000 $18.9m1.37% 1.37% AddedShares held: Q3 2021 1.7m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.2m +150.0k +150,000 7.3%
25 IRSA INVERSIONES Y REP S A GLOBL DEP RCPT IRS IRS 4,887,920 $17.6m1.27% 1.27% AddedShares held: Q3 2021 3.4m, Q4 2021 3.4m, Q1 2022 3.4m, Q2 2022 4.9m +1.5m +1,470,590 43.0%
26 ATARA BIOTHERAPEUTICS INC COM COM 2,045,000 $15.9m1.15% 1.15% AddedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 2.0m +215.0k +215,000 11.8%
27 PROG HOLDINGS INC COM NPV PRG PRG 940,000 $15.5m1.12% 1.12% ReducedShares held: Q3 2021 480.1k, Q4 2021 570.0k, Q1 2022 961.7k, Q2 2022 940.0k -21.7k -21,700 -2.3%
28 GLOBAL TECHNOLGY ACQSTN CORP CLASS A ORD GTAC GTAC 1,535,000 $15.3m1.10% 1.10% UnchangedShares held: Q3 2021 0, Q4 2021 505.0k, Q1 2022 1.5m, Q2 2022 1.5m
29 ROCKET INTERNET GRWT OPRT CO SHS CL A SHS CL A 1,500,000 $14.7m1.06% 1.06% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
30 ZALATORIS ACQUISITION CORP COM CL A COM CL A 1,485,000 $14.6m1.05% 1.05% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.5m, Q2 2022 1.5m
31 PANACEA ACQUISITION CORP II CL A SHS CL A SHS 1,480,000 $14.4m1.04% 1.04% UnchangedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
32 TG THERAPEUTICS INC COM TGTX TGTX 3,300,000 $14.0m1.01% 1.01% AddedShares held: Q3 2021 828.3k, Q4 2021 1.2m, Q1 2022 2.6m, Q2 2022 3.3m +701.1k +701,105 27.0%
33 CONCORD ACQUISITION CORP COM CL A COM CL A 1,340,000 $13.3m0.96% 0.96% UnchangedShares held: Q3 2021 2.1m, Q4 2021 200.0k, Q1 2022 1.3m, Q2 2022 1.3m
34 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 677,714 $13.0m0.94% 0.94% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 677.7k, Q2 2022 677.7k
35 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,440,000 $12.2m0.88% 0.88% AddedShares held: Q3 2021 0, Q4 2021 290.6k, Q1 2022 355.0k, Q2 2022 1.4m +1.1m +1,085,000 305.6%
36 IMMATICS N.V SHS IMTX IMTX 1,385,600 $12.1m0.87% 0.87% AddedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.3m, Q2 2022 1.4m +125.6k +125,600 10.0%
37 FIRST LT ACQUISITION GROUP I CL A CL A 1,200,000 $11.9m0.86% 0.86% UnchangedShares held: Q3 2021 0, Q4 2021 200.0k, Q1 2022 1.2m, Q2 2022 1.2m
38 SARISSA CAPITAL ACQUISITN CO CL A CL A 1,200,000 $11.9m0.86% 0.86% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
39 INVIVYD INC COM IVVD IVVD 3,603,637 $11.8m0.85% 0.85% AddedShares held: Q3 2021 0, Q4 2021 620.0k, Q1 2022 2.4m, Q2 2022 3.6m +1.3m +1,253,637 53.4%
40 ORION BIOTECH OPPORTUNTES CO CLASS A ORD SHS CLASS A ORD SHS 1,199,000 $11.7m0.84% 0.84% UnchangedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.2m, Q2 2022 1.2m
41 VACASA INC CLASS A COM CLASS A COM 3,850,000 $11.1m0.80% 0.80% AddedShares held: Q3 2021 0, Q4 2021 701.6k, Q1 2022 806.6k, Q2 2022 3.9m +3.0m +3,043,369 377.3%
42 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,440,000 $10.9m0.79% 0.79% AddedShares held: Q3 2021 1.3m, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m +85.0k +85,000 6.3%
43 AXONPRIME INFRSTCTR AQSTN CO CLASS A COM CLASS A COM 1,099,999 $10.6m0.77% 0.77% AddedShares held: Q3 2021 0, Q4 2021 1,000.0k, Q1 2022 1.1m, Q2 2022 1.1m +3 +3 0.0%
44 MACONDRAY CAP ACQUISITN CORP CLASS A ORD SHS CLASS A ORD SHS 999,999 $10.0m0.72% 0.72% UnchangedShares held: Q3 2021 995.0k, Q4 2021 1,000.0k, Q1 2022 1,000.0k, Q2 2022 1,000.0k
45 BRIDGETOWN HOLDINGS LTD COM CL A COM CL A 998,940 $9.9m0.72% 0.72% UnchangedShares held: Q3 2021 998.9k, Q4 2021 998.9k, Q1 2022 998.9k, Q2 2022 998.9k
46 PINE TECHNOLOGY ACQUISITN CO CLASS A COM CLASS A COM 1,000,000 $9.8m0.71% 0.71% UnchangedShares held: Q3 2021 0, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.0m
47 ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS CLASS A ORD SHS 1,000,000 $9.7m0.70% 0.70% UnchangedShares held: Q3 2021 900.0k, Q4 2021 900.0k, Q1 2022 1.0m, Q2 2022 1.0m
48 NOCTURNE ACQUISITION CORP ORDINARY SHARES ORDINARY SHARES 950,000 $9.7m0.70% 0.70% UnchangedShares held: Q3 2021 950.0k, Q4 2021 950.0k, Q1 2022 950.0k, Q2 2022 950.0k
49 QUANTUM FINTECH ACQUISTIN CO COMMON STOCK COMMON STOCK 950,000 $9.3m0.67% 0.67% UnchangedShares held: Q3 2021 0, Q4 2021 950.0k, Q1 2022 950.0k, Q2 2022 950.0k
50 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 1,900,000 $9.2m0.66% 0.66% ReducedShares held: Q3 2021 1.9m, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m -32.8k -32,829 -1.7%
51 GESHER I ACQUISITION CORP CLASS A ORD CLASS A ORD 900,000 $8.9m0.64% 0.64% UnchangedShares held: Q3 2021 0, Q4 2021 900.0k, Q1 2022 900.0k, Q2 2022 900.0k
52 TRITON INTL LTD CL A TRTN TRTN 160,300 $8.4m0.61% 0.61% AddedShares held: Q3 2021 0, Q4 2021 110.0k, Q1 2022 145.0k, Q2 2022 160.3k +15.3k +15,300 10.6%
53 MAIDEN HOLDINGS LTD SHS MHLD MHLD 4,350,534 $8.4m0.61% 0.61% ReducedShares held: Q3 2021 5.2m, Q4 2021 5.1m, Q1 2022 5.1m, Q2 2022 4.4m -768.5k -768,466 -15.0%
54 SOFTWARE ACQUISITN GRP INC I COM CL A COM CL A 800,000 $8.0m0.58% 0.58% UnchangedShares held: Q3 2021 790.0k, Q4 2021 800.0k, Q1 2022 800.0k, Q2 2022 800.0k
55 LIBERTY MEDIA ACQUISITION CO COM SR A COM SR A 794,435 $7.8m0.56% 0.56% UnchangedShares held: Q3 2021 508.4k, Q4 2021 794.4k, Q1 2022 794.4k, Q2 2022 794.4k
56 GALAPAGOS NV SPON ADR LKFT LKFT 136,192 $7.6m0.55% 0.55% ReducedShares held: Q3 2021 701.4k, Q4 2021 905.1k, Q1 2022 486.0k, Q2 2022 136.2k -349.8k -349,808 -72.0%
57 CRESUD S A C I F Y A SPONSORED ADR CRESY CRESY 1,484,409 $7.5m0.54% 0.54% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.6m, Q2 2022 1.5m -76.0k -76,018 -4.9%
58 COUNTER PRESS ACQUISITION CO CLASS A ORD SHS CLASS A ORD SHS 745,000 $7.4m0.54% 0.54% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 745.0k
59 OPY ACQUISITION CORP I COM CL A COM CL A 750,000 $7.4m0.53% 0.53% UnchangedShares held: Q3 2021 0, Q4 2021 250.0k, Q1 2022 750.0k, Q2 2022 750.0k
60 XERIS PHARMACEUTICALS INC NOTE 5.000% 7/1 · principal XERS 5 07.15.25 · principal XERS 5 07.15.25 7,950,000 $7.2m0.52% 0.52% UnchangedPrincipal held: Q3 2021 8.0m, Q4 2021 8.0m, Q1 2022 8.0m, Q2 2022 8.0m
61 VALUENCE MERGER CORP I CLASS A ORD SHS VMCAF VMCAF 700,000 $7.0m0.51% 0.51% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 700.0k
62 SQZ BIOTECHNOLOGIES CO COM SQZB SQZB 2,157,738 $6.9m0.50% 0.50% AddedShares held: Q3 2021 1.7m, Q4 2021 1.9m, Q1 2022 2.1m, Q2 2022 2.2m +58.9k +58,923 2.8%
63 EUCRATES BIOMEDICAL ACQU COR SHS SHS 600,000 $5.9m0.43% 0.43% UnchangedShares held: Q3 2021 600.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
64 ANGI INC COM CL A NEW COM CL A NEW 1,252,000 $5.7m0.41% 0.41% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.2m, Q1 2022 1.3m, Q2 2022 1.3m
65 NUVATION BIO INC COM CL A NUVB NUVB 1,766,657 $5.7m0.41% 0.41% AddedShares held: Q3 2021 246.4k, Q4 2021 246.4k, Q1 2022 1.3m, Q2 2022 1.8m +486.8k +486,757 38.0%
66 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 39,000 $5.7m0.41% 0.41% ReducedShares held: Q3 2021 49.0k, Q4 2021 49.0k, Q1 2022 49.0k, Q2 2022 39.0k -10.0k -10,000 -20.4%
67 CAPITAL ONE FINL CORP COM COF COF 50,000 $5.2m0.38% 0.38% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
68 ARGUS CAPITAL CORP CLASS A COM CLASS A COM 500,000 $5.0m0.36% 0.36% UnchangedShares held: Q3 2021 0, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
69 SOCIAL CAP SUVRETTA HLD CRPI CLASS A ORD SHS CLASS A ORD SHS 500,000 $5.0m0.36% 0.36% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 500.0k, Q2 2022 500.0k
70 TRINE II ACQUISITION CORP CL A ORD SHS CL A ORD SHS 500,000 $5.0m0.36% 0.36% UnchangedShares held: Q3 2021 0, Q4 2021 150.0k, Q1 2022 500.0k, Q2 2022 500.0k
71 GRAF ACQUISITION CORP IV COM COM 500,000 $4.9m0.35% 0.35% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
72 GIGINTERNATIONAL1 INC COM COM 480,000 $4.8m0.35% 0.35% UnchangedShares held: Q3 2021 480.0k, Q4 2021 480.0k, Q1 2022 480.0k, Q2 2022 480.0k
73 BANYAN ACQUISITION CORPORATI CL A COM PNSTQ PNSTQ 450,000 $4.5m0.32% 0.32% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 200.0k, Q2 2022 450.0k +250.0k +250,000 125.0%
74 CACTUS ACQUISITION CORP 1 LT CLASS A ORD CCTSF CCTSF 450,000 $4.5m0.32% 0.32% UnchangedShares held: Q3 2021 0, Q4 2021 225.0k, Q1 2022 450.0k, Q2 2022 450.0k
75 VECTOIQ ACQUISITION CORP II COM CL A COM CL A 454,001 $4.5m0.32% 0.32% UnchangedShares held: Q3 2021 454.0k, Q4 2021 454.0k, Q1 2022 454.0k, Q2 2022 454.0k
76 CYMABAY THERAPEUTICS INC COM CBAY CBAY 1,470,000 $4.3m0.31% 0.31% AddedShares held: Q3 2021 0, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.5m +370.0k +370,000 33.6%
77 COINBASE GLOBAL INC NOTE 0.500% 6/0 · principal COIN 0.5 06.01.26 · principal COIN 0.5 06.01.26 7,500,000 $4.3m0.31% 0.31% NewPrincipal held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 7.5m
78 LENNAR CORP CL B LEN.B LEN.B 72,900 $4.3m0.31% 0.31% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 39.0k, Q2 2022 72.9k +33.9k +33,900 86.9%
79 LIV CAPITAL ACQUISITN CORP I CLASS A ORD SHS CLASS A ORD SHS 405,000 $4.0m0.29% 0.29% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 155.0k, Q2 2022 405.0k +250.0k +250,000 161.3%
80 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,000,000 $4.0m0.29% 0.29% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 500.0k, Q2 2022 1.0m +500.0k +500,000 100.0%
81 ROTH CH ACQUISITION IV CO COM COM 400,000 $4.0m0.29% 0.29% UnchangedShares held: Q3 2021 390.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
82 AETHERIUM ACQUISITION CORP CLASS A COM CLASS A COM 400,000 $4.0m0.29% 0.29% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 400.0k, Q2 2022 400.0k
83 PROVIDENT ACQUISITION CORP CL A CL A 400,002 $3.9m0.28% 0.28% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
84 D AND Z MEDIA ACQUISITION CO COM CL A COM CL A 400,000 $3.9m0.28% 0.28% UnchangedShares held: Q3 2021 300.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
85 ACCRETION ACQUISITION CORP COM COM 375,000 $3.7m0.27% 0.27% UnchangedShares held: Q3 2021 0, Q4 2021 375.0k, Q1 2022 375.0k, Q2 2022 375.0k
86 NABORS ENERGY TRANSITION COR CL A COM CL A COM 350,000 $3.5m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 350.0k, Q2 2022 350.0k
87 RIGEL RESOURCE ACQ CORP CL A ORD SHS CL A ORD SHS 350,000 $3.5m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 50.0k, Q1 2022 350.0k, Q2 2022 350.0k
88 FTAC ZEUS ACQUISITION COR CLASS A COM CLASS A COM 350,000 $3.5m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 350.0k, Q2 2022 350.0k
89 KEYARCH ACQUISITION CORP ORD SHS CL A ORD SHS CL A 350,000 $3.4m0.25% 0.25% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 175.0k, Q2 2022 350.0k +175.0k +175,000 100.0%
90 INTERNATIONAL SEAWAYS INC COM INSW INSW 160,000 $3.4m0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 160.0k, Q1 2022 160.0k, Q2 2022 160.0k
91 WILLIAMS ROWLAND ACQUISITION COM COM 325,000 $3.2m0.23% 0.23% UnchangedShares held: Q3 2021 320.0k, Q4 2021 325.0k, Q1 2022 325.0k, Q2 2022 325.0k
92 CONTRAFECT CORP COM NEW CFRX CFRX 1,050,000 $3.2m0.23% 0.23% AddedShares held: Q3 2021 824.0k, Q4 2021 1.0m, Q1 2022 1.0m, Q2 2022 1.1m +50.0k +50,000 5.0%
93 B RILEY PRINCIPAL 150 MERGER COM CL A COM CL A 297,238 $3.0m0.21% 0.21% UnchangedShares held: Q3 2021 0, Q4 2021 297.2k, Q1 2022 297.2k, Q2 2022 297.2k
94 ARYA SCIENCES ACQU CORP IV CL A CL A 300,000 $2.9m0.21% 0.21% UnchangedShares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 300.0k
95 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 210,000 $2.8m0.20% 0.20% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 491.8k, Q2 2022 210.0k -281.8k -281,803 -57.3%
96 DIRTT ENVIRONMENTAL SOLUTION COM DRTTF DRTTF 2,333,400 $2.5m0.18% 0.18% ReducedShares held: Q3 2021 6.3m, Q4 2021 6.0m, Q1 2022 5.2m, Q2 2022 2.3m -2.9m -2,911,390 -55.5%
97 ALTENERGY ACQUISITION CORP COM CL A AEAE AEAE 250,000 $2.5m0.18% 0.18% UnchangedShares held: Q3 2021 0, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
98 FOCUS IMPACT ACQUISITION COR CLASS A COM CLASS A COM 250,000 $2.5m0.18% 0.18% UnchangedShares held: Q3 2021 0, Q4 2021 40.0k, Q1 2022 250.0k, Q2 2022 250.0k
99 ST ENERGY TRANSITION I LTD CL A ORD SHS CL A ORD SHS 250,000 $2.5m0.18% 0.18% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 250.0k, Q2 2022 250.0k
100 COVA ACQUISITION CORP CL A SHS CL A SHS 250,000 $2.5m0.18% 0.18% UnchangedShares held: Q3 2021 250.0k, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
HERBALIFE NUTRITION LTD HLF HLF 1,440,597 $43.7m1.4m shares
VIRGIN GROUP ACQUISIT CORP I 847,225 $8.4m847.2k shares
HELIX ACQUISITION CORP MLTX MLTX 790,000 $7.9m790.0k shares
COUNTER PRESS ACQUISITION CO 745,000 $7.5m745.0k shares
OAKTREE ACQUISITION CORP II 750,000 $7.5m750.0k shares
VALUENCE MERGER CORP I VMCUF VMCUF 700,000 $7.0m700.0k shares
IRSA PROPIEDADES COMERCIALES 2,626,044 $6.7m2.6m shares
STITCH FIX INC SFIX SFIX 364,000 $3.7m364.0k shares
BETTER WORLD ACQUISITION COR 300,000 $3.1m300.0k shares
GLOBIS ACQUISITION CORP 300,000 $3.1m300.0k shares
FIRSTENERGY CORP FE FE 58,500 $2.7m58.5k shares
BANYAN ACQUISITION CORPORATI 250,000 $2.5m250.0k shares
HAYMAKER ACQUISITION CORP II 253,334 $2.5m253.3k shares
LIV CAPITAL ACQUISITN CORP I 250,000 $2.5m250.0k shares
GORES GUGGENHEIM INC 200,000 $2.3m200.0k shares
KEYARCH ACQUISITION CORP 175,000 $1.8m175.0k shares
AMERICAS TECHNOLOGY ACQSN CO 150,000 $1.5m150.0k shares
ACKRELL SPAC PARTNERS I CO 150,000 $1.5m150.0k shares
CONSILIUM ACQUISITN CORP I L 150,000 $1.5m150.0k shares
METALLA RTY & STREAMING LTD MTA MTA 200,946 $1.4m200.9k shares
EURONAV NV CMBT CMBT 120,000 $1.3m120.0k shares
DIAGEO PLC DEO DEO 5,300 $1.1m5.3k shares
DILLARDS INC DDS DDS 3,300 $886.0k3.3k shares
SHELL MIDSTREAM PARTNERS L P SHLX SHLX 60,000 $853.0k60.0k shares
NEXTDECADE CORP NEXT NEXT 62,588 $414.0k62.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
AMC ENTMT HLDGS INC Put Put 1,399,400 $19.0m1.4m shares Reduced
UNITED STS OIL FD LP USO · Call USOCall 145,000 $11.7m145.0k shares Unchanged
AMC ENTMT HLDGS INC Call Call 89,500 $1.2m89.5k shares Reduced

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GOSSAMER BIO INC GOSS · 13G · filed 2026-06-11 GOSS 10.0%≈ $8.2m +6.1 pts 13G 2026-06-11
MEREO BIOPHARMA GROUP PLC MREO · 13G · filed 2026-01-06 MREO 8.2% new 13G 2026-01-06
IN8BIO INC INAB · 13G · filed 2025-12-30 INAB 7.9%≈ $1.1m new 13G 2025-12-30
IMMUNIC INC 13G · filed 2026-02-17 5.9% -4.0 pts 13G 2026-02-17